Transforming Lives Through Genetic Discovery
o Over two decades ago when we first opened our doors, we focused on giving much-needed attention to the underserved communities of those with rare diseases. These rare disease communities mostly affected children and were often ignored. At the time, BioMarin developed the only treatments for these life-altering conditions, giving hope to patients and families.
Throughout our history, we’ve worked tirelessly to make a difference by pursuing bold science while respecting, educating, and connecting with patients. Through our expertise in genetics and molecular biology, we have been able to develop targeted therapies that address the root cause of the exact conditions we seek to treat.
Our discoveries have led us to countless breakthroughs, best-in-class treatments and many ‘firsts’ in the category. We are grateful to able to better the lives of those struggling with genetic diseases.
As we look forward, we strive to make an even greater impact by applying the same science-driven, patient-forward approach to a broader range of genetic disorders.
The more innovative solutions we develop, the more lives we can impact.
This isn’t just our passion, it’s our purpose.
BioMarin at a Glance
-
Headquarters
San Rafael, California
-
Founded
1997
-
Chairman and CEO
Jean-Jacques Bienaimé
-
Employees
3,000
-
Ticker
NASDAQ: BMRN
-
Revenue 2021
$1.8 billion
-
Net Income (Loss) 2021
($64.1 million)
-
Focus
Genetic disorders
-
Products
PALYNZIQ® (pegvaliase-pqpz) Injection self-administered enzyme substitution therapy for PKU
Brineura® (cerliponase alfa) for CLN2 Disease
Vimizim® (elosulfase alfa) for MPS IVA
Kuvan® (sapropterin dihydrochloride) Tablets for Oral Use and Powder for Oral Solution for PKU
Naglazyme® (galsulfase) for MPS VI
Aldurazyme® (laronidase) for MPS I
VOXZOGO® (vosoritide) Injection for Achondroplasia -
Partners
Genzyme Corporation

More than twenty years of transforming lives through genetic discovery.
Learn More about our history ⌃We maximize the impact of genetic innovation to develop transformative therapies.
Each drug candidate we pursue is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address.
View Now Our Pipeline ⌃Leadership Team
Our management team represents a dynamic cross section of business, clinical and biotechnical expertise.
Learn More about our leadership team ⌃Diversity, Equity & Inclusion
We value diverse perspectives from a broad spectrum of backgrounds, education, personalities, skill sets, experiences, and knowledge.
Learn More about Diversity, Equity & Inclusion at BioMarin ⌃